ECM update: Jintian Pharma, Jianhua Concrete, Goldpoly
Jintian Pharmaceutical Group is looking to tap the Hong Kong IPO market having started premarketing for a $300m float on November 18.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts